NLRP3 and cardiovascular disorder: On one hand, statins are associated with reduced NLRP3 activation and downstream mediators like IL-1β, which may contribute to improved cardiac function For instance, one study demonstrated that statins could decrease NLRP3 gene expression in peripheral blood mononuclear cells from patients with cardiovascular disease, suggesting their anti-inflammatory potential under certain conditions [72].